Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001247898 | SCV001421350 | pathogenic | PRPH2-related disorder | 2023-11-06 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 202 of the PRPH2 protein (p.Gly202Glu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with autosomal dominant PRPH2-related conditions (PMID: 33546218; Invitae). ClinVar contains an entry for this variant (Variation ID: 971980). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on PRPH2 protein function. For these reasons, this variant has been classified as Pathogenic. |
Institute of Medical Molecular Genetics, |
RCV001353008 | SCV001548102 | likely pathogenic | Patterned macular dystrophy 1 | 2021-01-30 | criteria provided, single submitter | clinical testing |